¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell like colloidal drop"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell line
¼¼Æ÷ÁÖ, ¼¼Æ÷°è
cell loss
¼¼Æ÷¼Ò½Ç
cell mass
¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell organelle
¼¼Æ÷¼Ò±â°ü
cell respiration
¼¼Æ÷È£Èí
cell strain
¼¼Æ÷ÁÖ
cell substitution
¼¼Æ÷´ëü, Ç÷±¸´ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell swelling
¼¼Æ÷Á¾Ã¢
cell-associated antibody
¼¼Æ÷¿¬°üÇ×ü
cell-bound antibody
¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell-associated virus
¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
cell-mediated cytolysis
¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
cell-mediated cytotoxicity
¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
cell-mediated hypersensitivity
¼¼Æ÷¸Å°³°ú¹Î
cell-mediated immunity
¼¼Æ÷¸Å°³¸é¿ª
cell-mediated reaction
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated immunodeficiency syndrome
¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
cell-mediated lympholysis test
¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
centroacinar cell
»ù²Ê¸®Á߽ɼ¼Æ÷
chief cell
À¸¶ä¼¼Æ÷
Chinese hamster ovary cell
Áß±¹ºñ´ÜÅÐÁã³¼Ò¼¼Æ÷
chromaffin cell
ģũ·Ò¼¼Æ÷, Å©·Òģȼ¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
Ts cell
¾ïÁ¦T¼¼Æ÷
Tzanck cell
Á¤Å© ¼¼Æ÷
abnormality of cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
accessory cell
º¸Á¶¼¼Æ÷, ºÎ¼ö¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
¼±Æ÷ ¼¼Æ÷(àÍøàá¬øà)
acinar cell
¼±¹æ¼¼Æ÷(¡á¬øà)
acinic cell carcinoma
¼±¹æ¼¼Æ÷¾ÏÁ¾(¡á¬øàäßðþ)
acinic cell tumor
¼±¹æ¼¼Æ÷Á¾(¡á¬øàðþ)
activation, polyclonal B cell
´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
adamantinoid basal cell carcinoma
¹ý¶û Á¾¾ç(ÛöÕË ðþåÆ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
adult T Cell leukemia virus
¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
clear cell basal cell carcinoma
Åõ¸í¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
clear cell epinephrine cell
¹àÀº¼¼Æ÷ ¿¡Çdz×ÇÁ¸°¼¼Æ÷
cytotoxic T-cell ; killer T-cell
(¼¼Æ÷)»ì(ÇØ) T¼¼Æ÷.
dark cell norepinephrine cell
¾îµÎ¿î¼¼Æ÷ ³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷
interstitial cell dark cell
»çÀÌÁú¼¼Æ÷
interstitial cell leydigs cell
»çÀÌÁú¼¼Æ÷
lupus erythematosus cell = LE cell
È«¹Ý¼º ·çǪ½º¼¼Æ÷(¡á¬øà)
neurolemmal cell [schwanns cell]
½Å°æÁý¼¼Æ÷
pale cell acanthoma => clear cell acanthoma
parafollicular cell [calcitonin cell]
¼ÒÆ÷°ç¼¼Æ÷
plasma cell orificial mucositis => plasma cell cheilitis
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
secretory epithelial cell [glandular cell]
ºÐºñ»óÇǼ¼Æ÷ (»ù¼¼Æ÷)
supporting cell [sertoli cell]
¹öÆÀ¼¼Æ÷
supporting cell [type ii glomus cell]
¹öÆÀ¼¼Æ÷
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½